OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+11.41%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$796M
AUM Growth
+$796M
(+11%)
Cap. Flow
+$50.9M
Cap. Flow
% of AUM
6.4%
Top 10 Holdings %
Top 10 Hldgs %
88.61%
Holding
34
New
5
Increased
9
Reduced
5
Closed
2
Top Buys
1 |
Vir Biotechnology
VIR
|
$20.7M |
2 |
Atea Pharmaceuticals
AVIR
|
$10.8M |
3 |
QuidelOrtho
QDEL
|
$9.82M |
4 |
Guardant Health
GH
|
$8.75M |
5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$5.76M |
Top Sells
1 |
SPDR S&P Biotech ETF
XBI
|
$10.3M |
2 |
Capricor Therapeutics
CAPR
|
$5.98M |
3 |
DMTK
DermTech, Inc. Common Stock
DMTK
|
$1.4M |
4 |
MOTS
Motus GI Holdings, Inc. Common Stock
MOTS
|
$517K |
5 |
Biodesix
BDSX
|
$449K |
Sector Composition
1 | Healthcare | 99.94% |
2 | Energy | 0.06% |